Your browser doesn't support javascript.
loading
Pharmaceutically inhibiting polo-like kinase 1 exerts a broad anti-tumour activity in retinoblastoma cell lines.
Schwermer, Melanie; Dreesmann, Sabine; Eggert, Angelika; Althoff, Kristina; Steenpass, Laura; Schramm, Alexander; Schulte, Johannes H; Temming, Petra.
Afiliação
  • Schwermer M; Department of Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
  • Dreesmann S; Department of Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
  • Eggert A; Department of Pediatric Oncology and Hematology, Charité University Medicine Berlin, Berlin, Germany.
  • Althoff K; Department of Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
  • Steenpass L; Institute of Human Genetics, University Hospital Essen, Essen, Germany.
  • Schramm A; Department of Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
  • Schulte JH; Department of Pediatric Oncology and Hematology, Charité University Medicine Berlin, Berlin, Germany.
  • Temming P; Department of Pediatric Oncology and Hematology, University Hospital Essen, Essen, Germany.
Clin Exp Ophthalmol ; 45(3): 288-296, 2017 Apr.
Article em En | MEDLINE | ID: mdl-27647547

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Proteínas de Ciclo Celular / Neoplasias da Retina / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Proteínas Proto-Oncogênicas / Proteínas Serina-Treonina Quinases / Proteínas de Ciclo Celular / Neoplasias da Retina / Inibidores Enzimáticos / Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article